The director of Planning and Institutional Transformation of the IMSS, Arturo de Lucio Ortega, highlighted that for the first time they are working as a team with the aim of putting the patient at the center of the service and research.
The Mexican Institute of Social Security (IMSS) brought together specialists from the Health sector, academia and health authorities in the Ecosystem of Clinical Research and Advances in Nephrology forum, a space in which the main challenges and opportunities were analyzed to strengthen clinical research in kidney health, promote inter-institutional collaboration and promote the development of innovative treatments for the benefit of the population.
The event organized by the Planning Directorate for Institutional Transformation (DPTI) and the Medical Benefits Directorate (DPM) of Social Security took place at the Juan Moisés Calleja Theater of the IMSS. In this framework, the head of the Education and Research Unit, Dr. Rosana Pelayo Camacho, pointed out that the Institute has the maximum commitment to supporting clinical research in inter-institutional and sectoral collaboration, for the benefit of the health of the Mexican population.
“We have in common all the conviction, the struggle, the values, the sensitivity, but, above all, decades of study and commitment to the health of Mexico based on knowledge, innovation, universal rights to the benefits of science,” he said.
The director of Economic and Social Benefits, Dr. Mauricio Hernández Ávila, served as moderator of the research forum, in which topics such as clinical research in the IMSS, nephrological research, Mexican technology for renal replacement therapy, ethics and financing were addressed.
He stated that the work of making the IMSS or any institution a relevant research institution is a titanic task that requires joint work. “Research is necessary that transforms health, that has that impact.”
In her intervention, the IMSS Health Research Coordinator, Dr. Laura Bonifaz Alfonzo, highlighted that, thanks to the encouragement of the general director of Social Security, Zoé Robledo, research has been carried out from biomedical knowledge to translation and application; An example of this is the metabolic molecular carving project for diabetes, which can lead to kidney disease.
“We researchers are publishing around 1,900 publications per year, of which in kidney disease we have published 500 publications in recent years. The world cites us around 1.6 times, the number of times that the world turns to see what the IMSS is doing in kidney disease,” he indicated.
Finally, the director of Planning and Institutional Transformation of the IMSS, Arturo de Lucio Ortega, thanked the attendees for sharing their experience from civil society and regulation, with which for the first time they are working as a team in this matter, with the aim of putting the patient at the center of the service and research.
“The IMSS has the infrastructure, research centers, more than 700 researchers, laboratories, trained personnel, a management team that is leading the agenda,” he said.
Also present at the event were Dr. Ramón Paniagua, from the Nephrology Medical Research Unit, High Specialty Medical Unit (UMAE) Specialty Hospital; Dr. Sergio Iván Valdés Ferrer, general director of Research Policies of the Ministry of Health; Dr. Sonia Mayra Pérez Tapia, scientist and technologist at the National Polytechnic Institute (IPN); Dr. Rodrigo Bazúa Lobato, from the Health Authorization Commission of the Federal Commission for the Protection against Health Risks (Cofepris) and author of the book presented; as well as Dr. Alma Ortíz Pellón, deputy director of the Mexican Association to Fight Cancer (AMLCC).